Insulin aspart and insulin aspart protamine and Panitumumab
Determining the interaction of Insulin aspart and insulin aspart protamine and Panitumumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart and insulin aspart protamine-Panitumumab Intravenous
- Insulin aspart and insulin aspart protamine-Panixine
- Insulin aspart and insulin aspart protamine-Panixine DisperDose
- Insulin aspart and insulin aspart protamine-Panlor
- Insulin aspart and insulin aspart protamine-Panlor Tablet
- Insulin aspart and insulin aspart protamine-Panlor Tablets
- Panitumumab-Insulin aspart and insulin degludec Subcutaneous
- Panitumumab-Insulin Aspart Injection
- Panitumumab-Insulin Aspart Protamine and Insulin Aspart
- Panitumumab-Insulin aspart protamine and insulin aspart Subcutaneous
- Panitumumab-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Panitumumab-Insulin Aspart Protamine and Insulin Aspart (Vials)